Heart failure hospitalisation (RR) · heart failure with chronic kidney disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Worsening heart failure · heart failure with chronic kidney disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Worsening kidney function · heart failure with chronic kidney disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Hypotension · heart failure with chronic kidney disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Hyperkalaemia · heart failure with chronic kidney disease
CHRONIC: Aldosterone antagonists may leads to higher hyperkalaemia compared with placebo (low certainty).
1 finding from 1 review
Quality of life · heart failure with chronic kidney disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Efficacy and stability of fixation (bite force) · Adults with isolated mandibular fractures in the interforaminal region
1 finding from 1 review
Nausea · women seeking emergency contraception
Mid‐dose mifepristone (25 mg‐50 mg) showed no clear difference in specific side effect ‐ nausea compared with levonorgestrel 1.5 mg (low certainty).
1 finding from 1 review
Vomiting · women seeking emergency contraception
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Specific side effects ‐ spotting/bleeding after treatment · women seeking emergency contraception
Mid‐dose mifepristone (25 mg‐50 mg) may leads to lower specific side effect ‐ spotting/bleeding after treatment compared with levonorgestrel 1.5 mg (low certainty).
1 finding from 1 review
Menses ‐ early · women seeking emergency contraception
Mid‐dose mifepristone (25 mg‐50 mg) showed no clear difference in menses ‐ early compared with levonorgestrel 1.5 mg (low certainty).
1 finding from 1 review
Menses ‐ delay · women seeking emergency contraception
Mid‐dose mifepristone (25 mg‐50 mg) probably leads to higher menses ‐ delay compared with levonorgestrel 1.5 mg (moderate certainty).
1 finding from 1 review
Observed number of pregnancies (all women) · women seeking emergency contraception
Mid‐dose mifepristone (25 mg‐50 mg) probably leads to lower observed number of pregnancies (all women) compared with levonorgestrel 1.5 mg (moderate certainty).
1 finding from 1 review
Side effects · women seeking emergency contraception
Mid‐dose mifepristone (25 mg‐50 mg) may leads to lower any side effect compared with levonorgestrel 1.5 mg (low certainty).
1 finding from 1 review
Condition‐specific instruments designed to assess incontinence ‐ e.g. BFLUTS · women with recurrent stress urinary incontinence after failed minimally invasive midurethral tape surgery
1 finding from 1 review
no estimate extracted
46 participants
GRADE not reported
Repeat surgery for urinary incontinence · women with recurrent stress urinary incontinence after failed minimally invasive midurethral tape surgery
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events · women with recurrent stress urinary incontinence after failed minimally invasive midurethral tape surgery
1 finding from 1 review
no estimate extracted
46 participants
GRADE not reported
Number of women whose incontinence was improved or cured ‐ · women with recurrent stress urinary incontinence after failed minimally invasive midurethral tape surgery
1 finding from 1 review
no estimate extracted
46 participants
GRADE not reported
Objective cure rates in the longer‐term ‐ more than 12 months, · women with recurrent stress urinary incontinence after failed minimally invasive midurethral tape surgery
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
General health status evaluation e.g. Short Form (SF)‐36 ‐ not reported · women with recurrent stress urinary incontinence after failed minimally invasive midurethral tape surgery
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found